MGA and diffuse large B-cell lymphoma: Recurrent mutations in Mga were also reported in lymphoid malignancies, including Natural Killer/T-cell lymphoma (NKTCL) (Zhang et al, 2018; Kim & Ko, 2022), Chronic Lymphoid Leukemia (Edelmann et al, 2012; De Paoli et al, 2013; Puente et al, 2015) and diffuse large B-cell lymphoma (DLBCL) (Reddy et al, 2017; Lee et al, 2020).